This prospective , non-blinded randomized controlled non-inferiority trial seeks to enroll infants with elevated total serum/plasma bilirubin ( TSB , defined as 3 mg/dl below the level recommended by the American Academy of Pediatrics for high-risk infants requiring PT ) who will be randomly and equally assigned to receive FS-PT or CPT for a total of 616 days at an inner-city maternity hospital in Lagos , Nigeria .